<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00488501</url>
  </required_header>
  <id_info>
    <org_study_id>M06-16106</org_study_id>
    <nct_id>NCT00488501</nct_id>
  </id_info>
  <brief_title>Clinical Usefulness and Efficacy of Intrathoracic Impedance Monitoring Using the OptiVol Patient Alert(TM)</brief_title>
  <official_title>Clinical Usefulness and Efficacy of Intrathoracic Impedance Monitoring Using the OptiVol Patient Alert(TM) in Medtronic(R) ICD's for Early Detection of Decompensated Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Catharina Ziekenhuis Eindhoven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Catharina Ziekenhuis Eindhoven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study we investigate the clinical value and efficacy of OptiVol (TM) impedance
      measurements by Medtronic (R) ICD's. We aim to determine sensitivity and positive predictive
      value for detecting heart failure. We also investigate if left ventricular filling pattern
      measured by echocardiography and/or brain natriuretic peptide (BNP) level can be used to
      improve the positive predictive value of the Optivol alert
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients who have a Medtronic (R) ICD equipped with the Optivol (TM) impedance monitoring
      will be included in your study after informed consent. The OptiVol (TM) feature will be
      activated and at baseline data is collected (blood sample including BNP, electrocardiography,
      echocardiography, chest X-ray and ICD check-up). During follow-up patients will be
      re-assessed in case of an OptiVol alert or in case of heart failure.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2007</start_date>
  <completion_date type="Actual">January 2009</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>clinical efficacy and value of ambulatory intrathoracic impedance measurement of the Optivol alert as an indicator of decompensated heart failure reflected by sensitivity and positive predictive value</measure>
    <time_frame>end of follow-up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>influence of left ventricular filling pattern and brain natriuretic level on the positive predictive value of the Optivol alert</measure>
    <time_frame>end of follow-up</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">29</enrollment>
  <condition>Heart Failure</condition>
  <eligibility>
    <study_pop>
      <textblock>
        patients who have been implanted a biventricular pacemaker ICD equipped with impedance
        monitoring and who are known with chronic heart failure of any cause
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  chronic heart failure of any cause

          -  implanted Medtronic ICD with OptiVol impedance monitoring

        Exclusion Criteria:

          -  inability to receive informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>P Houthuizen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Catharina Ziekenhuis Eindhoven</affiliation>
  </overall_official>
  <overall_official>
    <last_name>A Meijer, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>Catharina Ziekenhuis Eindhoven</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Catharina Ziekenhuis</name>
      <address>
        <city>Eindhoven</city>
        <zip>5602 ZA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 19, 2007</study_first_submitted>
  <study_first_submitted_qc>June 19, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 20, 2007</study_first_posted>
  <last_update_submitted>November 9, 2009</last_update_submitted>
  <last_update_submitted_qc>November 9, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 10, 2009</last_update_posted>
  <responsible_party>
    <name_title>Mrs. A. van Pol-Spiering</name_title>
    <organization>Stichting Toegepast Wetenschappelijk Cardiologisch Onderzoek</organization>
  </responsible_party>
  <keyword>intrathoracic impedance</keyword>
  <keyword>cardiac resynchronization therapy</keyword>
  <keyword>heart failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

